Optimizing Patient Access to Orphan Medicinal Products: Lessons from Central and Eastern Europe
{{output}}
This study examines patient access to orphan medicinal products (OMPs) in Central and Eastern Europe (CEE) over the past five years, focusing on seven countries: Bulgaria, Czechia, Hungary, Poland, Romania, Slovakia, and Slovenia. While these jurisdictions hav... ...
